Loading...
Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial
BACKGROUND: As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessation moti...
Na minha lista:
Udgivet i: | BMC Res Notes |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653992/ https://ncbi.nlm.nih.gov/pubmed/29061161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2831-2 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|